Search Results - "Talei, Abdol-Rasoul"

Helios, CD73 and CD39 Induction in Regulatory T Cells Exposed to Adipose Derived Mesenchymal Stem Cells.

Authors: Fakhimi, Maryam Talei, Abdol-Rasoul Ghaderi, Abbas et al.

Source: Cell Journal (Yakhteh). Jul-Sep2020, Vol. 22 Issue 2, p236-244. 9p.

Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women

Authors: Kamali-Sarvestani, Eskandar Talei, Abdol-Rasoul Merat, Ahmad

Source: Cancer Letters. Nov2004, Vol. 215 Issue 1, p83-87. 5p.

Memory CD4 T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells.

Authors: Vahidi, Yasmin Faghih, Zahra Talei, Abdol-Rasoul et al.

Source: Cellular Oncology (2211-3428). Feb2018, Vol. 41 Issue 1, p1-11. 11p.

This result is not displayed to guests.
Login for full access.

Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement.

Authors: Azizi, Atefeh Mehdipour, Fereshteh Samadi, Morteza et al.

Source: BMC Immunology. 5/3/2024, Vol. 25 Issue 1, p1-14. 14p.

Adipose Derived Stem Cells Exert Immunomodulatory Effects on Natural Killer Cells in Breast Cancer.

Authors: Bahrami, Behdokht Hosseini, Ahmad Talei, Abdol-Rasoul et al.

Source: Cell Journal (Yakhteh). Spring2017, Vol. 19 Issue 1, p137-145. 9p. 7 Graphs.

Cytokine profile of CD4+CD25−FoxP3+ T cells in tumor-draining lymph nodes from patients with breast cancer.

Authors: Niakan, Andisheh Faghih, Zahra Talei, Abdol-Rasoul et al.

Source: Molecular Immunology. Dec2019, Vol. 116, p90-97. 8p.

Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer.

Authors: Balouchi-Anaraki, Sima Mohammadsadeghi, Sara Norouzian, Marzieh et al.

Source: Breast Disease. 2022, Vol. 41 Issue 1, p373-382. 10p.

Expression of major histocompatibility complex class I polypeptide-related sequence B in adipose-derived stem cells from breast cancer patients and normal individuals.

Authors: Mansourabadi, Zahra Razmkhah, Mahboobeh Mohtasebi, Maryam et al.

Source: Journal of Cancer Research & Therapeutics. Jul-Sep2019, Vol. 15 Issue 5, p1067-1072. 6p.

The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.

Authors: Mehdipour, Fereshteh Razmkhah, Mahboobeh Faghih, Zahra et al.

Source: Cellular Oncology (2211-3428). Jun2019, Vol. 42 Issue 3, p381-395. 15p.

Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.

Authors: Ahmadvand, Simin Faghih, Zahra Montazer, Mehdi et al.

Source: Cellular Oncology (2211-3428). Jun2019, Vol. 42 Issue 3, p343-356. 14p.

Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-α and TNF-β) and gamma interferon (IFN-γ) among Iranian women with breast cancer

Authors: Kamali-Sarvestani, Eskandar Merat, Ahmad Talei, Abdol-Rasoul

Source: Cancer Letters. Jun2005, Vol. 223 Issue 1, p113-119. 7p.

Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4+ T cells in the draining lymph nodes of breast cancer.

Authors: Ghods, Atri Mehdipour, Fereshteh Shariat, Mahmoud et al.

Source: Molecular Immunology. Sep2021, Vol. 137, p52-56. 5p.

Significance of TIM-3 expression by CD4+ and CD8+ T lymphocytes in tumor-draining lymph nodes from patients with breast cancer.

Authors: Shariati, Sahar Ghods, Atri Zohouri, Mahshid et al.

Source: Molecular Immunology. Dec2020, Vol. 128, p47-54. 8p.

TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes.

Authors: Ghods, Atri Ghaderi, Abbas Shariat, Mahmoud et al.

Source: Immunology Letters. May2019, Vol. 209, p36-44. 9p.

Mesenchymal stem cells induced anti‐inflammatory features in B cells from breast tumor draining lymph nodes.

Authors: Mehdipour, Fereshteh Razmkhah, Mahboobeh Rezaeifard, Somayeh et al.

Source: Cell Biology International. Dec2018, Vol. 42 Issue 12, p1658-1669. 12p.

Cancer and normal adipose‐derived mesenchymal stem cells (ASCs): Do they have differential effects on tumor and immune cells?

Authors: Razmkhah, Mahboobeh Mansourabadi, Zahra Mohtasebi, Maryam Sadat et al.

Source: Cell Biology International. Mar2018, Vol. 42 Issue 3, p334-343. 10p.

Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.

Authors: Faghih, Zahra Erfani, Nasrollah Haghshenas, Mohammad Reza et al.

Source: Immunology Letters. Mar2014, Vol. 158 Issue 1/2, p57-65. 9p.

Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response?

Authors: Razmkhah, Mahboobeh Jaberipour, Mansooreh Erfani, Nasrollah et al.

Source: Cellular Immunology. Jan2011, Vol. 266 Issue 2, p116-122. 7p.

TNF-α is produced by, but not limited to, T helper 1, 2, and 17 in breast tumor-draining lymph nodes.

Authors: Ghods, Atri Mehdipour, Fereshteh Rasolmali, Reza et al.

Source: Clinical Immunology. Dec2022, Vol. 245, pN.PAG-N.PAG. 1p.